REMARTE was established in 2020 under the leadership of Chairman of the Board, KAAN YILDIRIM, and has been serving the pharmaceutical sector since then. Our company’s headquarters are located in Istanbul, and REMARTE is part of a group of pharmaceutical companies founded by the YILDIRIM family. With 30 years of experience passed down through generations, this accumulation of knowledge and expertise continues under the REMARTE brand.
REMARTE primarily focuses on the Turkish pharmaceutical market and we have licensed products and products in the licensing process in Turkey. Additionally, REMARTE is the primary supplier under the Turkey Named Patient Program (NPP). Our company is recognized as a registered and accredited institution in this field and holds the status of an authorized institutional importer.
The focus areas of the YILDIRIM family’s pharmaceutical companies are as follows:
